In vitro glucuronidation of D-23129, a new anticonvulsant, by human liver microsomes and liver slices

Xenobiotica; the Fate of Foreign Compounds in Biological Systems
P J McNeillyJ M Strong

Abstract

1. The metabolic profile of D-23129, a new anticonvulsant agent, was studied in vitro using human liver microsomes and fresh liver slices. 2. Oxidative metabolism appeared to be minimal with D-23129. The percent mean total radioactivity not associated with the parent compound recovered from oxidative metabolism studies from three individual liver donors was 0.7% +/- 0.6 SD and was not significantly different from [14C]-D-23129 incubated with heat inactivated microsomes, mean = 0.5% +/- 0.4 SD. 3. Phase II conjugation dominated the metabolism of D-23129 producing two distinct N-glucuronides as the primary metabolites. These metabolites were identified by electrospray ionization LC/MS. 4. The apparent Km for one of the glucuronide metabolites was determined in human liver microsome preparations from two individual liver donors to be 131 and 264 microM respectively, Vmax determined for the same microsomal preparations yielded 48.9 and 59.9 pmol/min/mg protein.

References

Nov 1, 1987·Pharmacology & Toxicology·M L Dahl-Puustinen, L Bertilsson

❮ Previous
Next ❯

Citations

Nov 25, 2000·Toxicology·C Lerche-Langrand, H J Toutain
Feb 8, 2002·Journal of Clinical Pharmacology·Geraldine M FerronSteven Troy
Aug 14, 2012·Drug, Healthcare and Patient Safety·Michael A CilibertoMichael Wong
Jul 28, 2011·Neuropsychiatric Disease and Treatment·Judith Lz Weisenberg, Michael Wong
Feb 3, 2012·Therapeutics and Clinical Risk Management·Konrad RejdakStanislaw J Czuczwar
Jan 25, 2011·CNS Drugs·Linda J Stephen, Martin J Brodie
Nov 1, 2011·Drugs·Cinzia Fattore, Emilio Perucca
May 6, 2010·Drug Metabolism Reviews·Federica VacondioBernard Testa
Jan 5, 2001·Expert Opinion on Investigational Drugs·M C Walker, J W Sander
May 4, 2005·CNS Drug Reviews·G Blackburn-MunroR E Blackburn-Munro
Sep 26, 2000·Experimental and Molecular Pathology·A ShigematsuN Higashi
Jul 13, 2012·Expert Opinion on Pharmacotherapy·Gökce OrhanHolger Lerche
Mar 13, 2012·Expert Opinion on Pharmacotherapy·Philip N Patsalos, David J Berry
Apr 17, 2003·European Journal of Clinical Pharmacology·Robert HermannMathias Locher
Dec 17, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Karen MethlingPatrick J Bednarski
May 29, 2010·Pharmacological Reports : PR·Piotr CzuczwarStanisław J Czuczwar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.